MedCap AB (publ) OMXSTO:MCAP:
ABILIA ACQUIRES LIVASSURED
PURCHASE PRICE INCLUDES 9.5 MEUR INITIAL PAYMENT
POTENTIAL ADDITIONAL PAYMENT UP TO 4 MEUR BASED ON PROFIT GROWTH
ACQUISITION EXPECTED TO POSITIVELY IMPACT MEDCAP'S EARNINGS
Abilia Acquires Livassured
Earlier from Medcap Ab
- MCAP: Q2 2025 delivered double-digit sales and EBITA growth, with strong M&A momentum
- MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma
- MedCap's Business Area Specialty Pharma Acquires XGX Pharma
- MCAP: Q1 2025 delivered 7% sales growth, 17% EBITA margin, and strong M&A prospects